49.32
price up icon0.18%   0.125
 
loading
Precedente Chiudi:
$49.20
Aprire:
$49.11
Volume 24 ore:
1.78M
Relative Volume:
0.60
Capitalizzazione di mercato:
$120.99B
Reddito:
$43.23B
Utile/perdita netta:
$6.79B
Rapporto P/E:
12.31
EPS:
4.0051
Flusso di cassa netto:
$9.17B
1 W Prestazione:
-0.95%
1M Prestazione:
+5.31%
6M Prestazione:
-1.15%
1 anno Prestazione:
-10.15%
Intervallo 1D:
Value
$49.03
$49.33
Intervallo di 1 settimana:
Value
$49.02
$51.05
Portata 52W:
Value
$44.62
$60.12

Sanofi Adr Stock (SNY) Company Profile

Name
Nome
Sanofi Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
82,878
Name
Cinguettio
@sanofi
Name
Prossima data di guadagno
2024-10-25
Name
Ultimi documenti SEC
Name
SNY's Discussions on Twitter

Confronta SNY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
SNY
Sanofi Adr
49.28 119.89B 43.23B 6.79B 9.17B 4.0051
Drug Manufacturers - General icon
LLY
Lilly Eli Co
854.92 756.28B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
189.02 454.91B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
231.73 411.31B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
132.84 254.66B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
87.65 218.83B 63.43B 16.42B 14.72B 6.4861

Sanofi Adr Stock (SNY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-08 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2025-09-02 Aggiornamento Deutsche Bank Hold → Buy
2025-08-08 Aggiornamento JP Morgan Neutral → Overweight
2025-04-15 Iniziato Exane BNP Paribas Outperform
2025-03-21 Iniziato Goldman Neutral
2025-01-30 Aggiornamento Deutsche Bank Sell → Hold
2024-07-26 Reiterato Argus Buy
2024-01-23 Iniziato Morgan Stanley Equal-Weight
2024-01-16 Ripresa UBS Buy
2023-12-05 Downgrade JP Morgan Overweight → Neutral
2023-10-30 Downgrade Stifel Buy → Hold
2023-09-06 Aggiornamento Berenberg Hold → Buy
2023-07-14 Iniziato HSBC Securities Buy
2023-04-28 Downgrade Deutsche Bank Hold → Sell
2023-03-27 Aggiornamento Barclays Equal Weight → Overweight
2022-12-13 Ripresa Morgan Stanley Overweight
2022-08-12 Aggiornamento Deutsche Bank Sell → Hold
2022-08-09 Downgrade UBS Buy → Neutral
2022-05-23 Iniziato SVB Leerink Outperform
2021-09-27 Aggiornamento SVB Leerink Mkt Perform → Outperform
2021-01-15 Iniziato Deutsche Bank Sell
2020-09-29 Iniziato Berenberg Hold
2020-03-17 Aggiornamento Barclays Underweight → Equal Weight
2020-03-11 Aggiornamento Goldman Neutral → Buy
2020-02-11 Iniziato SVB Leerink Mkt Perform
2020-01-06 Aggiornamento JP Morgan Neutral → Overweight
2019-09-23 Aggiornamento Guggenheim Neutral → Buy
2019-09-20 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2019-09-03 Iniziato Bernstein Outperform
2019-08-14 Aggiornamento UBS Neutral → Buy
2018-12-11 Aggiornamento Jefferies Hold → Buy
2018-11-01 Aggiornamento Barclays Underweight → Equal Weight
2018-10-09 Iniziato Guggenheim Neutral
2018-09-10 Aggiornamento BofA/Merrill Neutral → Buy
2018-08-10 Aggiornamento Citigroup Neutral → Buy
2018-03-23 Aggiornamento Liberum Hold → Buy
2018-01-23 Downgrade Barclays Equal Weight → Underweight
2017-12-06 Downgrade BofA/Merrill Buy → Neutral
2017-12-01 Downgrade Morgan Stanley Overweight → Underweight
2017-11-15 Aggiornamento Barclays Underweight → Equal Weight
2017-08-30 Aggiornamento HSBC Securities Reduce → Hold
Mostra tutto

Sanofi Adr Borsa (SNY) Ultime notizie

pulisher
Oct 02, 2025

Leerink Partners Sticks to Its Buy Rating for Sanofi (SNYNF) - The Globe and Mail

Oct 02, 2025
pulisher
Sep 29, 2025

BostInno🗳️ Vote in Inno Madness round two | 💻 UKG announces layoffs - The Business Journals

Sep 29, 2025
pulisher
Sep 26, 2025

Sanofi Expands Insulin Savings Program To Cover All US Patients - Benzinga

Sep 26, 2025
pulisher
Sep 17, 2025

Sanofi Reports Early Brivekimig Data, Signals Strong Efficacy And Good Tolerability - Sahm

Sep 17, 2025
pulisher
Sep 16, 2025

AstraZeneca Puts Cambridge Expansion On Ice Adding Pressure On Starmer Ahead Of Trump Visit - Sahm

Sep 16, 2025
pulisher
Sep 12, 2025

Sanofi: Informations relatives au nombre de droits de vote et d'actions - GlobeNewswire Inc.

Sep 12, 2025
pulisher
Sep 10, 2025

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS® - Ariva

Sep 10, 2025
pulisher
Sep 05, 2025

Leerink Partners Sticks to Their Buy Rating for Sanofi (SNY) - The Globe and Mail

Sep 05, 2025
pulisher
Sep 04, 2025

What's Going On With Nektar Therapeutics Stock On Thursday? - Sahm

Sep 04, 2025
pulisher
Sep 04, 2025

Why Is Sanofi Stock Falling Thursday? - Sahm

Sep 04, 2025
pulisher
Sep 04, 2025

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors - Sahm

Sep 04, 2025
pulisher
Aug 26, 2025

New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week - Ariva

Aug 26, 2025
pulisher
Aug 21, 2025

European ADRs Under Pressure: Sector Divergence and Strategic Entry Points - AInvest

Aug 21, 2025
pulisher
Aug 05, 2025

Dupixent Leads the Charge for Sanofi's Strong Portfolio in Immunology, Vaccines, and Rare Diseases - Morningstar

Aug 05, 2025
pulisher
Aug 05, 2025

Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary - Seeking Alpha

Aug 05, 2025
pulisher
Aug 01, 2025

Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients - Sahm

Aug 01, 2025
pulisher
Jul 31, 2025

Sanofi ADR (SNY) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

Jul 31, 2025
pulisher
Jul 31, 2025

Sanofi ADR earnings beat by $0.63, revenue fell short of estimates - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SanofiSNY - cnhinews.com

Jul 27, 2025
pulisher
Jul 24, 2025

Sanofi: Reassessing Our Moat Rating for This Leader in Immunology, Vaccines, and Rare Diseases - Morningstar

Jul 24, 2025
pulisher
Jul 22, 2025

BEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study - Ariva

Jul 22, 2025
pulisher
Jul 21, 2025

AstraZeneca pledges $50 bln investment in US as pharma tariffs loom By Investing.com - Investing.com

Jul 21, 2025
pulisher
Jul 14, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SanofiSNY - FinancialContent

Jul 14, 2025

Sanofi Adr Azioni (SNY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$116.71
price down icon 0.32%
drug_manufacturers_general PFE
$26.36
price up icon 0.44%
$296.19
price up icon 0.24%
drug_manufacturers_general NVO
$59.82
price up icon 1.12%
drug_manufacturers_general MRK
$87.65
price up icon 0.01%
Capitalizzazione:     |  Volume (24 ore):